TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced operating and financial results for the fourth quarter and year ended December 31, 2007. For the fourth quarter and full year 2007, EpiCept’s net loss attributable to common stockholders was $6.2 million, or $0.14 per share, and $28.6 million, or $0.79 per share, respectively. As of December 31, 2007, EpiCept had cash and cash equivalents of $4.9 million, and approximately 45.9 million shares outstanding.
